Gilbert Gorr

This inventor holds 10 USPTO granted patents and 2 published patent applications, plus 7 CIPO patents and 9 EPO patents. Top assignees: Greenovation Biotech Gmbh, Phyton Holdings, LLC. Active years: 2009-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gilbert Gorr. Retrieved from https://idiyas.com/inventor/gilbert-gorr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 7

EPO Patents = 9 (Patent Applications = 4)

Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 10(Granted Patents)

Company Filing History:

7 out of 12

Greenovation Biotech Gmbh

Years Active: 2009-2020

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10822628 - Production of thapsigargins bycell suspension culture (2020-11-03),

2. 10253098 - Glyco-engineered antibodies (2019-04-09),

3. 10172306 - Production of ingenol, ingenol esters and/or tiglian-3-one derivatives by euphorbiaceae plant cell suspension cultures (2019-01-08),

4. 9051577 - Glyco-engineered antibodies (2015-06-09),

5. 8877501 - Production of alkaloids by liliaceae cell culture (2014-11-04),

6. 8790928 - Utilisation of constructs comprising recombination sequence motifs for enhancing gene expression in moss (2014-07-29),

7. 7834167 - Moss expressing promotion regions (2010-11-16),

8. 7781197 - Transformed bryophyte cell having disrupted endogenous alpha 1,3-fucosyl and beta 1,2-xylosyl transferase encoding nucleotide sequences for the production of heterologous glycosylated proteins (2010-08-24),

9. 7741539 - Transformed plant cell expressing five mammalian proteins involved in sialylation and a protein involved in galactosylation (2010-06-22),

10. 7538259 - Moss expressing promoting regions (2009-05-26),

Title: An Insight into the Innovations of Gilbert Gorr

Introduction

Gilbert Gorr is an accomplished inventor based in Freiburg, Germany, recognized for his significant contributions to the field of biotechnology. With a total of 10 patents to his name, he has been at the forefront of research and development, focusing on innovative solutions that impact the production of valuable compounds.

Latest Patents

Gorr's latest patents showcase his expertise in plant cell culture and antibody modifications. One standout invention is the method for the production of thapsigargins using suspension cell culture. This method involves culturing plant cells to produce sesquiterpene lactones of the thapsigargin family, followed by recovering these valuable compounds. Furthermore, he developed an innovative glyco-engineered antibody preparation, characterized by modified antibodies free of fucose and xylose, ensuring enhanced performance and specificity.

Career Highlights

Throughout his career, Gilbert Gorr has worked with prominent companies such as Greenovation Biotech GmbH and Phyton Holdings, LLC. His experience in these organizations has allowed him to develop groundbreaking technologies and contribute to advancements in biotechnology.

Collaborations

Gorr has collaborated with esteemed professionals in his field, including Wolfgang Jost and Christian Stemmer. These collaborations have facilitated the exchange of ideas and expertise, further enriching the innovations that Gorr has brought to life through his patents.

Conclusion

In summary, Gilbert Gorr's contributions to the field of biotechnology through his patents reflect a rich body of work that enhances our understanding and application of plant cell culture and antibody engineering. His dedication to innovation continues to inspire future advancements in the industry.

Profile summary based on public USPTO records.